Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740553 · ClinicalTrials.gov registry record · NA
Automated Stereognosis to Treat Loss of Tactile Function After Brain Injury
A NA study, sponsored by The University of Texas at Dallas.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT05740553 is a NA study that was terminated before completion, run by The University of Texas at Dallas. The registered enrollment target is 3 participants.
The verdict
NCT05740553, a NA study, was terminated before completion, sponsored by The University of Texas at Dallas.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Researchers aim to determine whether the ReTrieve system for tactile training can improve tactile function (sense of touch) in the hand after brain injury when used at home for 6 weeks.
Interventions
- DEVICE ReTrieve Automated Stereognosis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05740553
The ClinicalTrials.gov registry entry for NCT05740553 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ReTrieve Automated Stereognosis System is the first listed.
NCT05740553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05740553 about?
NCT05740553 is a clinical study titled "Automated Stereognosis to Treat Loss of Tactile Function After Brain Injury". Researchers aim to determine whether the ReTrieve system for tactile training can improve tactile function (sense of touch) in the hand after brain injury when used at home for 6 weeks.
What is the current status of trial NCT05740553?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-11-15. Estimated completion is 2022-06-06.
What interventions are being tested in trial NCT05740553?
The interventions under investigation include: ReTrieve Automated Stereognosis System (DEVICE).
Who is sponsoring clinical trial NCT05740553?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.